Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Improving intradermal drug delivery by highly accurate injection of small volumes in the skin

Latest news

HPV Vaccination Impact Study Rwanda

February 4 marks World Cancer Day

Today, 4 February, is #worldcancerday. Cervical cancer is one of the most preventable forms of cancer if it’s detected early. HPV urine testing can offer a solution for screening next to monitoring the impact of HPV vaccination.

Upcoming event

ECCMID 2019

ECCMID 2019

Amsterdam, NL
We're excited to attend the 29th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Amsterdam, Netherlands, from 13 - 16 April 2019. Hope to see you there!